IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER

Central Nervous System Metastases

Nancy Lin, MDmonoclonal_antibodyPhase 2Active

CCC

53/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 38/ 100
Competitive Position: 95/ 100

Competitive context

2 Active assets in the Central Nervous System Metastases cohort.

Asset / Sponsor	Phase	Rating
Lapatinib Jonsson Comprehensive Cancer Center	Phase 2	B
METHOTREXATE University of Washington	Phase 2	B
Cytosin-Arabinosid University of Washington	Phase 2	B
Atezolizumab Nancy Lin, MD	Phase 2	CCC
TRASTUZUMAB Nancy Lin, MD	Phase 2	CCC

View all 12 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER is also rated in:

breast carcinomaDormant

BBB

Indicative ·

75 / 100

View asset →

inflammatory breast carcinomaDormant

BBB

Indicative ·

72 / 100

View asset →

HER2 positive breast carcinomaDormant

Indicative ·